Diagnostic Value of Cerebrospinal Fluid Neurofilament Light Protein in Neurology: A Systematic Review and Meta-analysis

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement.

(2009) · PubMed Central · Cited by 44,859 · see citing works

Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement

Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & the PRISMA Group* (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-151-4-200908180-00135 · Cited by 37,554 · see citing works

The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

McKhann, G. M., Knopman, D. S., Chertkow, H., Hyman, B. T., Jack, C. R., Kawas, C. H., Klunk, W. E., Koroshetz, W. J., Manly, J. J., Mayeux, R., et al. (2011) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.03.005 · Cited by 18,657 · see citing works

QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies

Whiting, P. F., Rutjes, A. W. S., Westwood, M. E., Mallett, S., Deeks, J. J., Reitsma, J. B., Leeflang, M. M. G., Sterne, J. A. C., Bossuyt, P. M. M., & the QUADAS-2 Group* (2011) · Annals of Internal Medicine · doi:10.7326/0003-4819-155-8-201110180-00009 · Cited by 14,199 · see citing works

Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases.

Hughes, A. J., Daniel, S. E., Kilford, L., & Lees, A. J. (1992) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.55.3.181 · Cited by 10,378 · see citing works

Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria

Polman, C. H., Reingold, S. C., Banwell, B., Clanet, M., Cohen, J. A., Filippi, M., Fujihara, K., Havrdova, E., Hutchinson, M., Kappos, L., et al. (2011) · Annals of Neurology · doi:10.1002/ana.22366 · Cited by 9,802 · see citing works

Recommended diagnostic criteria for multiple sclerosis: Guidelines from the international panel on the diagnosis of multiple sclerosis

McDonald, W. I., Compston, A., Edan, G., Goodkin, D., Hartung, H., Lublin, F. D., McFarland, H. F., Paty, D. W., Polman, C. H., Reingold, S. C., et al. (2001) · Annals of Neurology · doi:10.1002/ana.1032 · Cited by 6,969 · see citing works

Frontotemporal lobar degeneration: A consensus on clinical diagnostic criteria

Neary, D., Snowden, J. S., Gustafson, L., Passant, U., Stuss, D., Black, S., Freedman, M., Kertesz, A., Robert, P. H., Albert, M., et al. (1998) · Neurology · doi:10.1212/wnl.51.6.1546 · Cited by 5,047 · see citing works

Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”

Polman, C. H., Reingold, S. C., Edan, G., Filippi, M., Hartung, H., Kappos, L., Lublin, F. D., Metz, L. M., McFarland, H. F., O'Connor, P. W., et al. (2005) · Annals of Neurology · doi:10.1002/ana.20703 · Cited by 5,017 · see citing works

Diagnosis and management of dementia with Lewy bodies: Fourth consensus report of the DLB Consortium

McKeith, I. G., Boeve, B. F., Dickson, D. W., Halliday, G., Taylor, J.-P., Weintraub, D., Aarsland, D., Galvin, J., Attems, J., Ballard, C. G., et al. (2017) · Neurology · doi:10.1212/wnl.0000000000004058 · Cited by 4,476 · see citing works

Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria

Dubois, B., Feldman, H. H., Jacova, C., Hampel, H., Molinuevo, J. L., Blennow, K., DeKosky, S. T., Gauthier, S., Selkoe, D., Bateman, R., et al. (2014) · The Lancet Neurology · doi:10.1016/s1474-4422(14)70090-0 · Cited by 3,321 · see citing works

Socioeconomic Inequalities in Health in 22 European Countries

Mackenbach, J. P., Stirbu, I., Roskam, A.-J. R., Schaap, M. M., Menvielle, G., Leinsalu, M., & Kunst, A. E. (2008) · New England Journal of Medicine · doi:10.1056/nejmsa0707519 · Cited by 3,289 · see citing works

Clinical diagnostic criteria for dementia associated with Parkinson’s disease

Emre, M., Aarsland, D., Brown, R., Burn, D. J., Duyckaerts, C., Mizuno, Y., Broe, G. A., Cummings, J., Dickson, D. W., Gauthier, S., et al. (2007) · Movement Disorders · doi:10.1002/mds.21507 · Cited by 3,027 · see citing works

Diagnostic Criteria for Parkinson Disease

Gelb, D. J., Oliver, E., & Gilman, S. (1999) · Archives of Neurology · doi:10.1001/archneur.56.1.33 · Cited by 2,822 · see citing works

Fruit and vegetable intake and the risk of cardiovascular disease, total cancer and all-cause mortality - a systematic review and dose-response meta-analysis of prospective studies

Aune, D., Giovannucci, E., Boffetta, P., Fadnes, L. T., Keum, N., Norat, T., Greenwood, D. C., Riboli, E., Vatten, L. J., & Tonstad, S. (2017) · International Journal of Epidemiology · doi:10.1093/ije/dyw319 · Cited by 2,419 · see citing works

Critical review: vegetables and fruit in the prevention of chronic diseases

Boeing, H., Bechthold, A., Bub, A., Ellinger, S., Haller, D., Kroke, A., Leschik‐Bonnet, E., Müller, M. J., Oberritter, H., Schulze, M. B., et al. (2012) · European Journal of Nutrition · doi:10.1007/s00394-012-0380-y · Cited by 1,776 · see citing works

Clinical and neuropathological criteria for frontotemporal dementia. The Lund and Manchester Groups.

(1994) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.57.4.416 · Cited by 1,331 · see citing works

Consensus statement on the diagnosis of multiple system atrophy

Gilman, S., Low, P. A., Quinn, N. P., Albanese, A., Ben‐Shlomo, Y., Fowler, C. J., Kaufmann, H., Klockgether, T., Lang, A. E., Lantos, P. L., et al. (1998) · Clinical Autonomic Research · doi:10.1007/bf02309628 · Cited by 1,316 · see citing works

The accuracy of diagnosis of parkinsonian syndromes in a specialist movement disorder service

Hughes, A. J., Daniel, S. E., Ben‐Shlomo, Y., & Lees, A. J. (2002) · Brain · doi:10.1093/brain/awf080 · Cited by 1,250 · see citing works

Diagnosing Idiopathic Normal-pressure Hydrocephalus

Relkin, N. R., Marmarou, A., Klinge, P. M., Bergsneider, M., & Black, P. M. (2005) · Neurosurgery · doi:10.1227/01.neu.0000168185.29659.c5 · Cited by 1,240 · see citing works

Fruit and vegetable consumption and stroke: meta-analysis of cohort studies

He, F. J., Nowson, C. A., & MacGregor, G. A. (2006) · The Lancet · doi:10.1016/s0140-6736(06)68069-0 · Cited by 1,108 · see citing works

Consensus statement on the diagnosis of multiple system atrophy

Gilman, S., Low, P. A., Quinn, N. P., Albanese, A., Ben‐Shlomo, Y., Fowler, C. J., Kaufmann, H., Klockgether, T., Lang, A. E., Lantos, P. L., et al. (1999) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(98)00304-9 · Cited by 915 · see citing works

A systematic review of socio-economic differences in food habits in Europe: consumption of fruit and vegetables

de Irala, J., Groth, M., Johansson, L., Oltersdorf, U., Prättälä, R., & Martínez‐González, M. Á. (2000) · European Journal of Clinical Nutrition · doi:10.1038/sj.ejcn.1601080 · Cited by 682 · see citing works

Variations in the relation between education and cause-specific mortality in 19 European populations: A test of the “fundamental causes” theory of social inequalities in health

Mackenbach, J. P., Kulhánová, I., Bopp, M., Deboosere, P., Eikemo, T. A., Hoffmann, R., Kulik, M. C., Leinsalu, M., Martikainen, P., Menvielle, G., et al. (2014) · Social Science & Medicine · doi:10.1016/j.socscimed.2014.05.021 · Cited by 576 · see citing works

Neurofilament light chain: A prognostic biomarker in amyotrophic lateral sclerosis

Lu, C.-H., Macdonald-Wallis, C., Gray, E., Pearce, N., Petzold, A., Norgren, N., Giovannoni, G., Fratta, P., Sidle, K., Fish, M., et al. (2015) · Neurology · doi:10.1212/wnl.0000000000001642 · Cited by 563 · see citing works

The Journal of Comparative Neurology

Wistar Institute of Anatomy and Biology. (2006) · The Journal of Comparative Neurology · doi:10.1002/(issn)1096-9861 · Cited by 536 · see citing works

Evidence of early cortical atrophy in MS

de Stefano, N., Matthews, P. M., Filippi, M., Agosta, F., Luca, M. D., Bartolozzi, M. L., Guidi, L., Ghezzi, A., Montanari, E., Cifelli, A., et al. (2003) · Neurology · doi:10.1212/01.wnl.0000055926.69643.03 · Cited by 519 · see citing works

Annals of Neurology

Ashwal, S., Bale, J. F., Coulter, D. L., Eiben, R., & Garg, B. P. (2006) · Annals of Neurology · doi:10.1002/(issn)1531-8249 · Cited by 514 · see citing works

Patients with Amyotrophic Lateral Sclerosis and Other Neurodegenerative Diseases Have Increased Levels of Neurofilament Protein in CSF

Rosengren, L. E., Karlsson, J., Karlsson, J., Persson, L. I., & Wikkelsø, C. (1996) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1996.67052013.x · Cited by 499 · see citing works

Association of Cerebrospinal Fluid Neurofilament Light Concentration With Alzheimer Disease Progression

Zetterberg, H., Skillbäck, T., Mattsson, N., Trojanowski, J. Q., Portelius, E., Shaw, L. M., Weiner, M. W., Blennow, K., & Initiative, F. T. A. D. N. (2016) · JAMA Neurology · doi:10.1001/jamaneurol.2015.3037 · Cited by 487 · see citing works

Increased Neurofilament Light Chain Blood Levels in Neurodegenerative Neurological Diseases

Gaiottino, J., Norgren, N., Dobson, R., Topping, J. H., Nissim, A., Malaspina, A., Bestwick, J. P., Monsch, A. U., Regeniter, A., Lindberg, R. L. P., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0075091 · Cited by 486 · see citing works

A revision of the El Escorial criteria - 2015

Ludolph, A. C., Drory, V. E., Hardiman, O. M., Nakano, I., Ravits, J., Robberecht, W., Shefner, J. M., & for The WFN Research Group On ALS/MND (2015) · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · doi:10.3109/21678421.2015.1049183 · Cited by 477 · see citing works

Accuracy of a Panel of 5 Cerebrospinal Fluid Biomarkers in the Differential Diagnosis of Patients With Dementia and/or Parkinsonian Disorders

Hall, S., Öhrfelt, A., Constantinescu, R., Andreasson, U., Surova, Y., Bostrom, F., Nilsson, C., Widner, H., Decraemer, H., Nägga, K., et al. (2012) · Archives of Neurology · doi:10.1001/archneurol.2012.1654 · Cited by 473 · see citing works

Clinicopathological correlations in corticobasal degeneration

Lee, S. E., Rabinovici, G. D., Mayo, M. C., Wilson, S. M., Seeley, W. W., DeArmond, S. J., Huang, E. J., Trojanowski, J. Q., Growdon, M. E., Jang, J. Y., et al. (2011) · Annals of Neurology · doi:10.1002/ana.22424 · Cited by 434 · see citing works

Are interventions to promote healthy eating equally effective for all? Systematic review of socioeconomic inequalities in impact

McGill, R., Anwar, E., Orton, L., Bromley, H., Lloyd-Williams, F., O’Flaherty, M., Taylor-Robinson, D., Guzman-Castillo, M., Gillespie, D., Moreira, P., et al. (2015) · BMC Public Health · doi:10.1186/s12889-015-1781-7 · Cited by 407 · see citing works

Educational differences in disability-free life expectancy: a comparative study of long-standing activity limitation in eight European countries

Mäki, N., Martikainen, P., Eikemo, T. A., et al. (2013) · Social Science & Medicine · doi:10.1016/j.socscimed.2013.06.009 · Cited by 353 · see citing works

Fruit, Vegetable, and Antioxidant Intake and All-Cause, Cancer, and Cardiovascular Disease Mortality in a Community-dwelling Population in Washington County, Maryland

Genkinger, J. M., Platz, E. A., Hoffman, S. C., Comstock, G. W., & Helzlsouer, K. J. (2004) · American Journal of Epidemiology · doi:10.1093/aje/kwh339 · Cited by 351 · see citing works

Accuracy of clinical criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome)

Litvan, I., Agid, Y., Jankovic, J. J., Goetz, C. G., Brandel, J., Lai, E. C., Wenning, G. K., D'Olhaberriague, L., Verny, M., Chaudhuri, К. R., et al. (1996) · Neurology · doi:10.1212/wnl.46.4.922 · Cited by 347 · see citing works

Axonal damage in relapsing multiple sclerosis is markedly reduced by natalizumab

Gunnarsson, M., Malmeström, C., Axelsson, M., Sundström, P., Dahle, C., Vrethem, M., Olsson, T. P., Piehl, F., Norgren, N., Rosengren, L., et al. (2010) · Annals of Neurology · doi:10.1002/ana.22247 · Cited by 346 · see citing works

Neurofilament light protein and glial fibrillary acidic protein as biological markers in MS

Malmeström, C., Haghighi, S., Rosengren, L., Andersen, O., & Lycke, J. (2003) · Neurology · doi:10.1212/01.wnl.0000098880.19793.b6 · Cited by 318 · see citing works

Assessing the validity of the Global Activity Limitation Indicator in fourteen European countries

Berger, N., Oyen, H. J. V., Cambois, E., Fouweather, T., Jagger, C., Nusselder, W. J., & Robine, J. (2015) · BMC Medical Research Methodology · doi:10.1186/1471-2288-15-1 · Cited by 317 · see citing works

Fruit and vegetable consumption and the risk of depression: A meta-analysis

Liu, X., Yan, Y., Li, F., & Zhang, D. (2015) · Nutrition · doi:10.1016/j.nut.2015.09.009 · Cited by 287 · see citing works

Inflammation, demyelination, and degeneration — Recent insights from MS pathology

Stadelmann, C., Wegner, C., & Brück, W. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2010.07.007 · Cited by 276 · see citing works

Quantification of mutant huntingtin protein in cerebrospinal fluid from Huntington’s disease patients

Wild, E. J., Boggio, R., Langbehn, D. R., Robertson, N., Salman, H., Miller, J. R. C., Zetterberg, H., Leavitt, B. R., Kuhn, R. R., Tabrizi, S. J., et al. (2015) · Journal of Clinical Investigation · doi:10.1172/jci80743 · Cited by 265 · see citing works

CSF neurofilament light differs in neurodegenerative diseases and predicts severity and survival

Skillbäck, T., Farahmand, B., Bartlett, J. W., Rosén, C., Mattsson, N., Nägga, K., Kilander, L., Religa, D., Wimo, A., Winblad, B., et al. (2014) · Neurology · doi:10.1212/wnl.0000000000001015 · Cited by 263 · see citing works

Neurofilament light chain: a biomarker for genetic frontotemporal dementia

Meeter, L. H., Dopper, E. G., Jiskoot, L. C., Sanchez‐Valle, R., Graff, C., Benussi, L., Ghidoni, R., Pijnenburg, Y. A., Borroni, B., Galimberti, D., et al. (2016) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.325 · Cited by 263 · see citing works

A panel of nine cerebrospinal fluid biomarkers may identify patients with atypical parkinsonian syndromes

Magdalinou, N. K., Paterson, R. W., Schott, J. M., Fox, N. C., Mummery, C. J., Blennow, K., Bhatia, K. P., Morris, H. R., Giunti, P., Warner, T. T., et al. (2015) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2014-309562 · Cited by 250 · see citing works

The Global Activity Limitation Index measured function and disability similarly across European countries

Jagger, C., Gillies, C. L., Cambois, E., Oyen, H. J. V., Nusselder, W. J., & Robine, J. (2010) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2009.11.002 · Cited by 250 · see citing works

Cerebrospinal fluid neurofilament concentration reflects disease severity in frontotemporal degeneration

Scherling, C. S., Hall, T., Berisha, F., Klepac, K., Karydas, A., Coppola, G., Kramer, J. H., Rabinovici, G., Ahlijanian, M., Miller, B. L., et al. (2014) · Annals of Neurology · doi:10.1002/ana.24052 · Cited by 249 · see citing works

Neurofilament and glial fibrillary acidic protein in multiple sclerosis

Norgren, N., Sundström, P., Svenningsson, A., Rosengren, L., Stigbrand, T. I., & Gunnarsson, M. (2004) · Neurology · doi:10.1212/01.wnl.0000142988.49341.d1 · Cited by 241 · see citing works

Comparison of Different Clinical Criteria (DSM-III, ADDTC, ICD-10, NINDS-AIREN, DSM-IV) for the Diagnosis of Vascular Dementia

Pohjasvaara, T., Mäntylä, R., Ylikoski, R., Kaste, M., & Erkinjuntti, T. (2000) · Stroke · doi:10.1161/01.str.31.12.2952 · Cited by 238 · see citing works

CSF biomarkers and clinical progression of Parkinson disease

Hall, S., Surova, Y., Öhrfelt, A., Zetterberg, H., Lindqvist, D., & Hansson, O. (2014) · Neurology · doi:10.1212/wnl.0000000000001098 · Cited by 236 · see citing works

Neurofilaments as biomarkers in multiple sclerosis

Teunissen, C. E., & Khalil, M. (2012) · Multiple Sclerosis Journal · doi:10.1177/1352458512443092 · Cited by 234 · see citing works

Disability outcome measures in multiple sclerosis clinical trials: current status and future prospects

Cohen, J. A., Reingold, S. C., Polman, C. H., & Wolinsky, J. S. (2012) · The Lancet Neurology · doi:10.1016/s1474-4422(12)70059-5 · Cited by 233 · see citing works

Accuracy of the clinical diagnosis of vascular dementia: a prospective clinical and post-mortem neuropathological study.

Erkinjuntti, T., Haltia, M., Palo, J., Sulkava, R. O., & Paetau, A. E. (1988) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.51.8.1037 · Cited by 229 · see citing works

Inequalities in Alcohol-Related Mortality in 17 European Countries: A Retrospective Analysis of Mortality Registers

Mackenbach, J. P., Kulhánová, I., Bopp, M., Borrell, C., Deboosere, P., Kovács, K., Looman, C. W. N., Leinsalu, M., Mäkelä, P., Martikainen, P., et al. (2015) · PLoS Medicine · doi:10.1371/journal.pmed.1001909 · Cited by 222 · see citing works

Cerebrospinal Fluid Patterns and the Risk of Future Dementia in Early, Incident Parkinson Disease

Bäckström, D. C., Domellöf, M. E., Linder, J., Olsson, B., Öhrfelt, A., Trupp, M., Zetterberg, H., Blennow, K., & Forsgren, L. (2015) · JAMA Neurology · doi:10.1001/jamaneurol.2015.1449 · Cited by 197 · see citing works

Diagnostic criteria for corticobasal syndrome: a comparative study

Mathew, R., Bak, T. H., & Hodges, J. R. (2011) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2011-300875 · Cited by 195 · see citing works

Idiopathic normal-pressure hydrocephalus

Jeppsson, A., Zetterberg, H., Blennow, K., & Wikkelsø, C. (2013) · Neurology · doi:10.1212/wnl.0b013e31828c2fda · Cited by 183 · see citing works

Cerebrospinal Fluid Matrix Metalloproteinases and Tissue Inhibitor of Metalloproteinases in Combination with Subcortical and Cortical Biomarkers in Vascular Dementia and Alzheimer's Disease

Bjerke, M., Zetterberg, H., Edman, Å., Blennow, K., Wallin, A., & Andreasson, U. (2011) · Journal of Alzheimer's Disease · doi:10.3233/jad-2011-110566 · Cited by 180 · see citing works

Fingolimod and CSF neurofilament light chain levels in relapsing-remitting multiple sclerosis

Kühle, J., Disanto, G., Lorscheider, J., Stites, T. E., Chen, Y., Dahlke, F., Francis, G., Shrinivasan, A., Radue, E. W., Giovannoni, G., et al. (2015) · Neurology · doi:10.1212/wnl.0000000000001491 · Cited by 176 · see citing works

Biomarker Evidence of Axonal Injury in Neuroasymptomatic HIV-1 Patients

Jessen Krut, J., Mellberg, T., Price, R. W., Hagberg, L., Fuchs, D., Rosengren, L., Nilsson, S., Zetterberg, H., & Gisslén, M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0088591 · Cited by 167 · see citing works

Glial and neuronal markers in cerebrospinal fluid predict progression in multiple sclerosis

Mañé-Martínez, M. A., Olsson, B., Bau, L., Matas, E., Cobo‐Calvo, Á., Andréasson, U., Blennow, K., Romero-Pinel, L., Martínez‐Yélamos, S., & Zetterberg, H. (2015) · Multiple Sclerosis Journal · doi:10.1177/1352458514549397 · Cited by 166 · see citing works

Neurofilament light in CSF and serum is a sensitive marker for axonal white matter injury in MS

Bergman, J., Dring, A. M., Zetterberg, H., Blennow, K., Norgren, N., Gilthorpe, J. D., Bergenheim, T. A., & Svenningsson, A. (2016) · Neurology Neuroimmunology & Neuroinflammation · doi:10.1212/nxi.0000000000000271 · Cited by 166 · see citing works

Fruit and Vegetable Consumption and Mortality

Leenders, M., Sluijs, I., Ros, M. M., Boshuizen, H. C., Siersema, P. D., Ferrari, P., Weikert, C., Tjønneland, A., Olsen, A., Boutron-Ruault, M.-C., et al. (2013) · American Journal of Epidemiology · doi:10.1093/aje/kwt006 · Cited by 163 · see citing works

Neurofilament light chain protein as a marker of neuronal injury: review of its use in HIV-1 infection and reference values for HIV-negative controls

Yilmaz, A., Blennow, K., Hagberg, L., Nilsson, S., Price, R. W., Schouten, J., Spudich, S., Underwood, J., Zetterberg, H., & Gisslén, M. (2017) · Expert Review of Molecular Diagnostics · doi:10.1080/14737159.2017.1341313 · Cited by 159 · see citing works

A comparative study of CSF neurofilament light and heavy chain protein in MS

Kuhle, J., Plattner, K., Bestwick, J. P., Lindberg, R. L., Ramagopalan, S. V., Norgren, N., Nissim, A., Malaspina, A., Leppert, D., Giovannoni, G., et al. (2013) · Multiple Sclerosis Journal · doi:10.1177/1352458513482374 · Cited by 155 · see citing works

Fruit and vegetable consumption and all-cause mortality: a dose-response analysis

Bellavia, A., Larsson, S. C., Bottai, M., Wolk, A., & Orsini, N. (2013) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.112.056119 · Cited by 153 · see citing works

Elevated cerebrospinal fluid neurofilament light levels in patients with amyotrophic lateral sclerosis: a possible marker of disease severity and progression

Tortelli, R., Ruggieri, M., Cortese, R., D’Errico, E., Capozzo, R., Leo, A., Mastrapasqua, M., Zoccolella, S., Leante, R., Livrea, P., et al. (2012) · European Journal of Neurology · doi:10.1111/j.1468-1331.2012.03777.x · Cited by 151 · see citing works

Unhealthy behaviours and disability in older adults: Three-City Dijon cohort study

Artaud, F., Dugravot, A., Sabia, S., Singh‐Manoux, A., Tzourio, C., & Elbaz, A. (2013) · BMJ · doi:10.1136/bmj.f4240 · Cited by 144 · see citing works

CSF neurofilament light chain reflects corticospinal tract degeneration in ALS

Menke, R., Gray, E., Lu, C., Kühle, J., Talbot, K., Malaspina, A., & Turner, M. R. (2015) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.212 · Cited by 141 · see citing works

Levels and Age Dependency of Neurofilament Light and Glial Fibrillary Acidic Protein in Healthy Individuals and Their Relation to the Brain Parenchymal Fraction

Vågberg, M., Norgren, N., Dring, A. M., Lindqvist, T., Birgander, R., Zetterberg, H., & Svenningsson, A. (2015) · PLoS ONE · doi:10.1371/journal.pone.0135886 · Cited by 141 · see citing works

Movement Disorders

Frank, S., Wilson, R. M., Holloway, R. G., Zimmerman, C. F., Peterson, D. R., Kieburtz, K. D., & Kim, S. Y. H. (2006) · Movement Disorders · doi:10.1002/(issn)1531-8257 · Cited by 131 · see citing works

Natalizumab in progressive MS

Christensen, J. R., Ratzer, R. L., Börnsen, L. S., Lyksborg, M., Garde, E., Dyrby, T. B., Siebner, H. R., Sørensen, P. S., & Sellebjerg, F. T. (2014) · Neurology · doi:10.1212/wnl.0000000000000361 · Cited by 127 · see citing works

Immunosuppressive therapy reduces axonal damage in progressive multiple sclerosis

Axelsson, M., Malmeström, C., Gunnarsson, M., Zetterberg, H., Sundström, P., Lycke, J., & Svenningsson, A. (2013) · Multiple Sclerosis Journal · doi:10.1177/1352458513490544 · Cited by 126 · see citing works

Measuring disability: a systematic review of the validity and reliability of the Global Activity Limitations Indicator (GALI)

Oyen, H. J. V., Bogaert, P., Yokota, R. T. C., & Berger, N. (2018) · Archives of Public Health · doi:10.1186/s13690-018-0270-8 · Cited by 126 · see citing works

CSF sAPPβ, YKL-40, and neurofilament light in frontotemporal lobar degeneration

Alcolea, D., Vilaplana, E., Suárez-Calvet, M., Illán-Gala, I., Blesa, R., Clarimón, J., Lladó, A., Sánchez-Valle, R., Molinuevo, J. L., García-Ribas, G., et al. (2017) · Neurology · doi:10.1212/wnl.0000000000004088 · Cited by 123 · see citing works

Cerebrospinal fluid levels of chitinase 3-like 1 and neurofilament light chain predict multiple sclerosis development and disability after optic neuritis

Modvig, S., Degn, M., Roed, H., Sørensen, T., Larsson, H. B. W., Langkilde, A., Frederiksen, J. L., & Sellebjerg, F. T. (2015) · Multiple Sclerosis Journal · doi:10.1177/1352458515574148 · Cited by 120 · see citing works

Cerebrospinal Fluid Biomarker and Brain Biopsy Findings in Idiopathic Normal Pressure Hydrocephalus

Pyykkö, O. T., Lumela, M., Rummukainen, J. K., Nerg, O., Seppälä, T. T., Herukka, S., Koivisto, A. M., Alafuzoff, I. I., Puli, L., Savolainen, S., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0091974 · Cited by 114 · see citing works

Neurofilament ELISA validation

Petzold, A., Altintas, A., Andreoni, L., Bartos, A., Berthele, A., Blankenstein, M. A., Buee, L., Castellazzi, M., Cepok, S., Comabella, M., et al. (2010) · Journal of Immunological Methods · doi:10.1016/j.jim.2009.09.014 · Cited by 105 · see citing works

Novel diagnostic cerebrospinal fluid biomarkers for pathologic subtypes of frontotemporal dementia identified by proteomics

Teunissen, C. E., Elias, N., Koel‐Simmelink, M. J. A., Durieux‐Lu, S., Malekzadeh, A., Pham, T. V., Piersma, S. R., Beccari, T., Meeter, L. H. H., Dopper, E. G. P., et al. (2016) · Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring · doi:10.1016/j.dadm.2015.12.004 · Cited by 103 · see citing works

Fruit and vegetable consumption and all-cause mortality: evidence from a large Australian cohort study

Nguyen, B., Bauman, A. E., Gale, J., Banks, E., Kritharides, L., & Ding, D. (2016) · International Journal of Behavioral Nutrition and Physical Activity · doi:10.1186/s12966-016-0334-5 · Cited by 96 · see citing works

Neuronal and Glia-Related Biomarkers in Cerebrospinal Fluid of Patients with Acute Ischemic Stroke

Hjalmarsson, C., Bjerke, M., Andersson, B., Blennow, K., Zetterberg, H., Åberg, N. D., Olsson, B., Eckerström, C., Bokemark, L., & Wallin, A. (2014) · Journal of Central Nervous System Disease · doi:10.4137/jcnsd.s13821 · Cited by 94 · see citing works

Elevated Concentrations of Neurofilament Light Chain in the Cerebrospinal Fluid of Bipolar Disorder Patients

Jakobsson, J., Bjerke, M., Ekman, C. J., Sellgren, C. M., Johansson, A. G. M., Zetterberg, H., Blennow, K., & Landén, M. (2014) · Neuropsychopharmacology · doi:10.1038/npp.2014.81 · Cited by 91 · see citing works

Discriminative and prognostic potential of cerebrospinal fluid phosphoTau/tau ratio and neurofilaments for frontotemporal dementia subtypes

Pijnenburg, Y. A. L., Verwey, N. A., van der Flier, W. M., Scheltens, P., & Teunissen, C. E. (2015) · Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring · doi:10.1016/j.dadm.2015.11.001 · Cited by 91 · see citing works

Neurofilament light and heavy subunits compared as therapeutic biomarkers in multiple sclerosis

Kühle, J., Malmeström, C., Axelsson, M., Plattner, K., Yaldizli, Ö., Derfuss, T. J., Giovannoni, G., Kappos, L., & Lycke, J. (2013) · Acta Neurologica Scandinavica · doi:10.1111/ane.12151 · Cited by 86 · see citing works

Assessing tissue damage in multiple sclerosis: a biomarker approach

Burman, J., Zetterberg, H., Fransson, M., Loskog, A., Raininko, R., & Fagius, J. (2014) · Acta Neurologica Scandinavica · doi:10.1111/ane.12239 · Cited by 86 · see citing works

CSF neurofilament and N-acetylaspartate related brain changes in clinically isolated syndrome

Khalil, M., Enzinger, C., Langkammer, C., Ropele, S., MADER, A., Trentini, A., Vane, M., Wallner-Blazek, M., Bachmaier, G., Archelos, J.-J., et al. (2012) · Multiple Sclerosis Journal · doi:10.1177/1352458512458010 · Cited by 85 · see citing works

Intense Inflammation and Nerve Damage in Early Multiple Sclerosis Subsides at Older Age: A Reflection by Cerebrospinal Fluid Biomarkers

Khademi, M., Dring, A. M., Gilthorpe, J. D., Wuolikainen, A., Nimer, F. A., Harris, R. A., Andersson, M., Brundin, L., Piehl, F., Olsson, T. P., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0063172 · Cited by 84 · see citing works

CSF neurofilament protein analysis in the differential diagnosis of ALS

Reijn, T. S., Abdo, W. F., Schelhaas, H. J., & Verbeek, M. M. (2009) · Journal of Neurology · doi:10.1007/s00415-009-0131-z · Cited by 80 · see citing works

CSF Neurofilament Light Chain but not FLT3 Ligand Discriminates Parkinsonian Disorders

Herbert, M. K., Aerts, M. B., Beenes, M., Norgren, N., Esselink, R. A. J., Bloem, B. R., Kuiperij, H. B., & Verbeek, M. M. (2015) · Frontiers in Neurology · doi:10.3389/fneur.2015.00091 · Cited by 77 · see citing works

The First Pan-European Sociological Health Inequalities Survey of the General Population: The European Social Survey Rotating Module on the Social Determinants of Health

Eikemo, T. A., Bambra, C. L., Huijts, T., & Fitzgerald, R. (2016) · European Sociological Review · doi:10.1093/esr/jcw019 · Cited by 75 · see citing works

Biomarkers of Inflammation and Axonal Degeneration/Damage in Patients with Newly Diagnosed Multiple Sclerosis: Contributions of the Soluble CD163 CSF/Serum Ratio to a Biomarker Panel

Stilund, M., Carstensen, M., Petersen, T., Møller, H. J., Rasmussen, P. V., & Christensen, T. (2015) · PLoS ONE · doi:10.1371/journal.pone.0119681 · Cited by 73 · see citing works

Long-term trends of inequalities in mortality in 6 European countries

de Gelder, R., Menvielle, G., Costa, G., Kovács, K., Martikainen, P., Strand, B. H., & Mackenbach, J. P. (2016) · International Journal of Public Health · doi:10.1007/s00038-016-0922-9 · Cited by 69 · see citing works

Fruit and vegetable intake and cause-specific mortality in the EPIC study

Leenders, M. B., Boshuizen, H. C., Ferrari, P., Siersema, P. D., Overvad, K., Tjønneland, A. M., Olsen, A., Boutron‐Ruault, M., Dossus, L., Dartois, L., et al. (2014) · European Journal of Epidemiology · doi:10.1007/s10654-014-9945-9 · Cited by 69 · see citing works

Cerebrospinal fluid neurofilament light chain levels: marker of progression to generalized amyotrophic lateral sclerosis

Tortelli, R., Copetti, M., Ruggieri, M., Cortese, R., Capozzo, R., Leo, A., D’Errico, E., Mastrapasqua, M., Zoccolella, S., Pellegrini, F., et al. (2014) · European Journal of Neurology · doi:10.1111/ene.12421 · Cited by 67 · see citing works

Complement Component C3 and Butyrylcholinesterase Activity Are Associated with Neurodegeneration and Clinical Disability in Multiple Sclerosis

Aeinehband, S., Lindblom, R. P. F., Nimer, F. A., Vijayaraghavan, S., Sandholm, K., Khademi, M., Olsson, T. P., Nilsson, B., Ekdahl, K. N., Darreh‐Shori, T., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0122048 · Cited by 65 · see citing works

Fruit and vegetable consumption and risk of lung cancer: A dose–response meta-analysis of prospective cohort studies

Wang, Y., Li, F. R., Wang, Z., Qiu, T., Shen, Y., & Wang, M. (2015) · Lung Cancer · doi:10.1016/j.lungcan.2015.02.015 · Cited by 64 · see citing works

Relationship between Cerebrospinal Fluid Biomarkers for Inflammation, Demyelination and Neurodegeneration in Acute Optic Neuritis

Modvig, S., Degn, M., Horwitz, H., Cramer, S. P., Larsson, H. B. W., Wanscher, B., Sellebjerg, F. T., & Frederiksen, J. L. (2013) · PLoS ONE · doi:10.1371/journal.pone.0077163 · Cited by 63 · see citing works

Neurofilament light protein in CSF and blood is associated with neurodegeneration and disease severity in Huntington’s disease R6/2 mice

Soylu-Kucharz, R., Sandelius, Å., Sjögren, M., Blennow, K., Wild, E. J., Zetterberg, H., & Björkqvist, M. (2017) · Scientific Reports · doi:10.1038/s41598-017-14179-1 · Cited by 63 · see citing works

Dissecting IWG-2 typical and atypical Alzheimer’s disease: insights from cerebrospinal fluid analysis

Paterson, R. W., Toombs, J., Slattery, C. F., Nicholas, J. M., Andréasson, U., Magdalinou, N. K., Blennow, K., Warren, J. D., Mummery, C. J., Rossor, M. N., et al. (2015) · Journal of Neurology · doi:10.1007/s00415-015-7904-3 · Cited by 56 · see citing works

Cerebrospinal fluid immunological biomarkers associated with axonal damage in multiple sclerosis

Villar, L. M., Picón, C., Costa‐Frossard, L., Alenda, R., García‐Caldentey, J., Espiño, M., Muriel, A., & Álvarez‐Cermeño, J. C. (2014) · European Journal of Neurology · doi:10.1111/ene.12579 · Cited by 56 · see citing works

Cerebrospinal fluid neurofilament light chain levels predict visual outcome after optic neuritis

Modvig, S., Degn, M., Sander, B., Horwitz, H., Wanscher, B., Sellebjerg, F. T., & Frederiksen, J. L. (2015) · Multiple Sclerosis Journal · doi:10.1177/1352458515599074 · Cited by 54 · see citing works

N-Acetylaspartate and neurofilaments as biomarkers of axonal damage in patients with progressive forms of multiple sclerosis

Trentini, A., Comabella, M., Tintoré, M., Koel‐Simmelink, M. J. A., Killestein, J., Roos, B., Rovira, À., Korth, C., Ottis, P., Blankenstein, M. A., et al. (2014) · Journal of Neurology · doi:10.1007/s00415-014-7507-4 · Cited by 54 · see citing works

Comparison of International Working Group criteria and National Institute on Aging–Alzheimer's Association criteria for Alzheimer's disease

Visser, P. J., Vos, S. J. B., van Rossum, I., & Scheltens, P. (2012) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2011.10.008 · Cited by 54 · see citing works

Smoking and the potential for reduction of inequalities in mortality in Europe

Kulik, M. C., Hoffmann, R., Judge, K., Looman, C. W. N., Menvielle, G., Kulhánová, I., Toch-Marquardt, M., Östergren, O., Martikainen, P., Borrell, C., et al. (2013) · European Journal of Epidemiology · doi:10.1007/s10654-013-9860-5 · Cited by 53 · see citing works

Cognitive Performance and Cerebrospinal Fluid Biomarkers of Neurodegeneration: A Study of Patients with Bipolar Disorder and Healthy Controls

Rolstad, S., Jakobsson, J., Sellgren, C. M., Ekman, C. J., Blennow, K., Zetterberg, H., Pålsson, E., & Landén, M. (2015) · PLoS ONE · doi:10.1371/journal.pone.0127100 · Cited by 52 · see citing works

Obesity and the potential reduction of social inequalities in mortality: evidence from 21 European populations

Hoffmann, R., Eikemo, T. A., Kulhánová, I., Kulik, M. C., Looman, C. W. N., Menvielle, G., Deboosere, P., Martikainen, P., Regidor, E., & Mackenbach, J. P. (2015) · European Journal of Public Health · doi:10.1093/eurpub/ckv090 · Cited by 52 · see citing works

Computerized reaction time battery versus a traditional neuropsychological battery: Detecting HIV-related impairments

González, R., Heaton, R. K., Moore, D. J., Letendre, S. L., Ellis, R. J., Wolfson, T. J., Marcotte, T. D., Cherner, M., Rippeth, J. D., Grant, I., et al. (2003) · Journal of the International Neuropsychological Society · doi:10.1017/s1355617703910071 · Cited by 51 · see citing works

Vitamin D and axonal injury in multiple sclerosis

Sandberg, L., Biström, M., Salzer, J., Vågberg, M., Svenningsson, A., & Sundström, P. (2015) · Multiple Sclerosis Journal · doi:10.1177/1352458515606986 · Cited by 49 · see citing works

Comparison of clinical and neuropathologic diagnoses of Alzheimer's disease in 3 epidemiologic samples

Plassman, B. L., Khachaturian, A. S., Townsend, J. J., Ball, M. J., Steffens, D. C., Leslie, C., Tschanz, J. T., Norton, M. C., Burke, J. R., Welsh-Bohmer, K. A., et al. (2006) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2005.11.001 · Cited by 47 · see citing works

The potential impact of a social redistribution of specific risk factors on socioeconomic inequalities in mortality: illustration of a method based on population attributable fractions

Hoffmann, R., Eikemo, T. A., Kulhánová, I., Dahl, E. S., Deboosere, P., Dzúrová, D., Oyen, H. J. V., Rychtaříková, J., Strand, B. H., & Mackenbach, J. P. (2012) · Journal of Epidemiology & Community Health · doi:10.1136/jech-2011-200886 · Cited by 47 · see citing works

Cell-free mitochondrial DNA in CSF is associated with early viral rebound, inflammation, and severity of neurocognitive deficits in HIV infection

Pérez‐Santiago, J., Schrier, R. D., Oliveira, M. F., Gianella, S., Var, S. R., Day, T. R. C., Ramirez-Gaona, M., Suben, J. D., Murrell, B., Massanella, M., et al. (2015) · Journal of NeuroVirology · doi:10.1007/s13365-015-0384-5 · Cited by 39 · see citing works

Levels of cerebrospinal fluid neurofilament light protein in healthy elderly vary as a function of TOMM40 variants

Bruno, D., Pomara, N., Nierenberg, J. J., Ritchie, J., Lutz, M. W., Zetterberg, H., & Blennow, K. (2011) · Experimental Gerontology · doi:10.1016/j.exger.2011.09.008 · Cited by 39 · see citing works

Cerebrospinal fluid levels of neurofilament light chain in multiple system atrophy relative to Parkinson’s disease: a meta-analysis

Hu, X., Yan, Y., & Gong, D. (2016) · Neurological Sciences · doi:10.1007/s10072-016-2783-7 · Cited by 37 · see citing works

Cerebrovascular Biomarker Profile Is Related to White Matter Disease and Ventricular Dilation in a LADIS Substudy

Bjerke, M., Jonsson, M. A. G., Nordlund, A., Eckerström, C., Blennow, K., Zetterberg, H., Pantoni, L., Inzitari, D., Schmidt, R., & Wallin, A. (2014) · Dementia and Geriatric Cognitive Disorders Extra · doi:10.1159/000366119 · Cited by 32 · see citing works

Cerebrospinal fluid biomarkers in cardiac arrest survivors

Rosén, C., Rosén, H., Andréasson, U., Bremell, D., Bremler, R., Hagberg, L., Rosengren, L., Blennow, K., & Zetterberg, H. (2013) · Resuscitation · doi:10.1016/j.resuscitation.2013.10.032 · Cited by 32 · see citing works

Increased intake of vegetables, but not fruits, may be associated with reduced risk of hip fracture: A meta-analysis

Luo, S. Y., Li, Y., Luo, H. L., Yin, X. H., Lin, D. R., Zhao, K., Huang, G. L., & Song, J. K. (2016) · Scientific Reports · doi:10.1038/srep19783 · Cited by 29 · see citing works

Table of Contents by Topic

(2005) · Neurosurgery · doi:10.1093/neurosurgery/57.3.n4 · Cited by 26 · see citing works

Serum and cerebrospinal fluid heavy neurofilaments and antibodies against them in early multiple sclerosis

Fialová, L., Bartoš, A., Švarcová, J., Zimová, D., & Kotoucova, J. (2013) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2013.03.009 · Cited by 25 · see citing works

Low cerebrospinal fluid sulfatide predicts progression of white matter lesions: The LADIS study

Jonsson, M., Zetterberg, H., Rolstad, S., Edman, A., Gouw, A. A., Bjerke, M., Lind, K., Blennow, K., Pantoni, L., Inzitari, D., et al. (2012) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000341576 · Cited by 22 · see citing works

Non-neurological surgery and cerebrospinal fluid biomarkers for neuronal and astroglial integrity

Anckarsäter, R., Anckarsäter, H. S., Bromander, S., Blennow, K., Wass, C., & Zetterberg, H. (2014) · Journal of Neural Transmission · doi:10.1007/s00702-013-1156-0 · Cited by 21 · see citing works

Cerebrospinal fluid neurofilament tracks fMRI correlates of attention at the first attack of multiple sclerosis

Tortorella, C., Direnzo, V., Taurisano, P., Romano, R., Ruggieri, M., Zoccolella, S., Mastrapasqua, M., Popolizio, T., Blasi, G., Bertolino, A., et al. (2014) · Multiple Sclerosis Journal · doi:10.1177/1352458514546789 · Cited by 19 · see citing works

After the storm

Giovannoni, G., & Nath, A. (2011) · Neurology · doi:10.1212/wnl.0b013e3182143345 · Cited by 19 · see citing works

Neurofilaments and tau proteins in cerebrospinal fluid and serum in dementias and neuroinflammation

Fialová, L., Bartoš, A., & Švarcová, J. (2017) · Biomedical Papers · doi:10.5507/bp.2017.038 · Cited by 15 · see citing works

Impact of Question Wording on the Measurement of Activity Limitation

Cambois, E., Grobon, S., Oyen, H. J. V., et al. (2016) · Journal of Aging and Health · doi:10.1177/0898264316656504 · Cited by 11 · see citing works

A Comparison of Two Methods of Measuring Food Group Intake: Grams vs Servings

Nöthlings, U., Murphy, S. P., Sharma, S., et al. (2006) · Journal of the American Dietetic Association · doi:10.1016/j.jada.2006.02.006 · Cited by 10 · see citing works

Neurodegenerative and inflammatory biomarkers in cerebrospinal fluid in patients with Cushing's syndrome in remission

Ragnarsson, Ó., Berglund, P., Eder, D. N., Zetterberg, H., Hietala, M. A., Blennow, K., & Johannsson, G. (2013) · European Journal of Endocrinology · doi:10.1530/eje-13-0205 · Cited by 7 · see citing works

Neocortical neuron number in humans: Effect of sex and age

(1997) · doi:10.1002/(sici)1096-9861(19970728)384:2

Determinants of disparities between perceived and physiological risk of falling among elderly people: cohort study.

(2010) · doi:10.1136/bmj

Alzheimer's disease

Scheltens, P., De Strooper, B., Kivipelto, M., Holstege, H., Chételat, G., Teunissen, C. E., Cummings, J., & van der Flier, W. M. (2021) · The Lancet · doi:10.1016/s0140-6736(20)32205-4 · Cited by 5,465 · see citing works

Alzheimer Disease: An Update on Pathobiology and Treatment Strategies

Long, J. M., & Holtzman, D. M. (2019) · Cell · doi:10.1016/j.cell.2019.09.001 · Cited by 3,204 · see citing works

Revised criteria for diagnosis and staging of Alzheimer's disease: Alzheimer's Association Workgroup

Jack, C. R., Andrews, J. S., Beach, T. G., Buracchio, T., Dunn, B., Graf, A., Hansson, O., Ho, C., Jagust, W., McDade, E., et al. (2024) · Alzheimer's & Dementia · doi:10.1002/alz.13859 · Cited by 2,803 · see citing works

Blood-based biomarkers for Alzheimer's disease: towards clinical implementation

Teunissen, C. E., Verberk, I. M. W., Thijssen, E. H., Vermunt, L., Hansson, O., Zetterberg, H., van der Flier, W. M., Mielke, M. M., & del Campo, M. (2022) · The Lancet Neurology · doi:10.1016/s1474-4422(21)00361-6 · Cited by 1,045 · see citing works

Diagnostic value of plasma phosphorylated tau181 in Alzheimer's disease and frontotemporal lobar degeneration

Advancing Research and Treatment for Frontotemporal Lobar Degeneration (ARTFL) investigators, Thijssen, E. H., La Joie, R., Wolf, A., Strom, A., Wang, P., Iaccarino, L., Bourakova, V., Cobigo, Y., Heuer, H., et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-0762-2 · Cited by 761 · see citing works

New insights into atypical Alzheimer's disease in the era of biomarkers

Graff-Radford, J., Yong, K. X. X., Apostolova, L. G., Bouwman, F. H., Carrillo, M., Dickerson, B. C., Rabinovici, G. D., Schott, J. M., Jones, D. T., & Murray, M. E. (2021) · The Lancet Neurology · doi:10.1016/s1474-4422(20)30440-3 · Cited by 706 · see citing works

The Alzheimer's Association appropriate use recommendations for blood biomarkers in Alzheimer's disease

Hansson, O., Edelmayer, R. M., Boxer, A. L., Carrillo, M. C., Mielke, M. M., Rabinovici, G. D., Salloway, S., Sperling, R., Zetterberg, H., & Teunissen, C. E. (2022) · Alzheimer's & Dementia · doi:10.1002/alz.12756 · Cited by 607 · see citing works

A multicentre validation study of the diagnostic value of plasma neurofilament light.

Ashton, N. J., Janelidze, S., Al Khleifat, A., Leuzy, A., van der Ende, E. L., Karikari, T. K., Benedet, A. L., Pascoal, T. A., Lleó, A., Parnetti, L., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-23620-z · Cited by 545 · see citing works

Neurofilaments as biomarkers in neurological disorders — towards clinical application

Khalil, M., Teunissen, C. E., Lehmann, S., Otto, M., Piehl, F., Ziemssen, T., Bittner, S., Sormani, M. P., Gattringer, T., Abu‐Rumeileh, S., et al. (2024) · Nature Reviews Neurology · doi:10.1038/s41582-024-00955-x · Cited by 480 · see citing works

Biomarkers for Alzheimer’s disease—preparing for a new era of disease-modifying therapies

Zetterberg, H., & Bendlin, B. B. (2020) · Molecular Psychiatry · doi:10.1038/s41380-020-0721-9 · Cited by 379 · see citing works

Recommendations to distinguish behavioural variant frontotemporal dementia from psychiatric disorders

Ducharme, S., Dols, A., Laforce, R., Devenney, E., Kumfor, F., van den Stock, J., Dallaire-Théroux, C., Seelaar, H., Gossink, F., Vijverberg, E., et al. (2020) · Brain · doi:10.1093/brain/awaa018 · Cited by 320 · see citing works

Blood neurofilament light: a critical review of its application to neurologic disease

Barro, C., Chitnis, T., & Weiner, H. L. (2020) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.51234 · Cited by 296 · see citing works

Neurofilament Proteins as Biomarkers to Monitor Neurological Diseases and the Efficacy of Therapies

Yuan, A., & Nixon, R. A. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.689938 · Cited by 290 · see citing works

Combination of plasma amyloid beta(1-42/1-40) and glial fibrillary acidic protein strongly associates with cerebral amyloid pathology

Verberk, I. M. W., Thijssen, E., Koelewijn, J., Mauroo, K., Vanbrabant, J., de Wilde, A., Zwan, M. D., Verfaillie, S. C. J., Ossenkoppele, R., Barkhof, F., et al. (2020) · Alzheimer's Research & Therapy · doi:10.1186/s13195-020-00682-7 · Cited by 258 · see citing works

Brain-derived tau: a novel blood-based biomarker for Alzheimer’s disease-type neurodegeneration

González‐Ortiz, F., Turton, M., Kac, P. R., Smirnov, D. S., Premi, E., Ghidoni, R., Benussi, L., Cantoni, V., Saraceno, C., Rivolta, J., et al. (2022) · Brain · doi:10.1093/brain/awac407 · Cited by 261 · see citing works

Multiple system atrophy

Fanciulli, A., Stanković, I., Krismer, F., Seppi, K., Levin, J., & Wenning, G. K. (2019) · International review of neurobiology · doi:10.1016/bs.irn.2019.10.004 · Cited by 253 · see citing works

The potential of serum neurofilament as biomarker for multiple sclerosis

Bittner, S., Oh, J., Havrdová, E., Tintoré, M., & Zipp, F. (2021) · Brain · doi:10.1093/brain/awab241 · Cited by 230 · see citing works

Moving fluid biomarkers for Alzheimer’s disease from research tools to routine clinical diagnostics

Zetterberg, H., & Blennow, K. (2021) · Molecular Neurodegeneration · doi:10.1186/s13024-021-00430-x · Cited by 219 · see citing works

Sex and gender differences in cognitive resilience to aging and Alzheimer's disease

Arenaza‐Urquijo, E. M., Boyle, R., Casaletto, K., Anstey, K. J., Vila‐Castelar, C., Colverson, A., Palpatzis, E., Eissman, J. M., Kheng Siang Ng, T., Raghavan, S., et al. (2024) · Alzheimer's & Dementia · doi:10.1002/alz.13844 · Cited by 223 · see citing works

Plasma phospho-tau in Alzheimer’s disease: towards diagnostic and therapeutic trial applications

González‐Ortiz, F., Kac, P. R., Brum, W. S., Zetterberg, H., Blennow, K., & Karikari, T. K. (2023) · Molecular Neurodegeneration · doi:10.1186/s13024-023-00605-8 · Cited by 217 · see citing works

Advances and controversies in frontotemporal dementia: diagnosis, biomarkers, and therapeutic considerations

Boeve, B. F., Boxer, A. L., Kumfor, F., Pijnenburg, Y., & Rohrer, J. D. (2022) · The Lancet Neurology · doi:10.1016/s1474-4422(21)00341-0 · Cited by 218 · see citing works

Specific associations between plasma biomarkers and postmortem amyloid plaque and tau tangle loads

Salvadó, G., Ossenkoppele, R., Ashton, N. J., Beach, T. G., Serrano, G. E., Reiman, E. M., Zetterberg, H., Mattsson‐Carlgren, N., Janelidze, S., Blennow, K., et al. (2023) · EMBO Molecular Medicine · doi:10.15252/emmm.202217123 · Cited by 205 · see citing works

Guidance for use of neurofilament light chain as a cerebrospinal fluid and blood biomarker in multiple sclerosis management

Freedman, M. S., Gnanapavan, S., Booth, R. A., Calabresi, P. A., Khalil, M., Kühle, J., Lycke, J., & Olsson, T. P. (2024) · EBioMedicine · doi:10.1016/j.ebiom.2024.104970 · Cited by 203 · see citing works

Differential levels of plasma biomarkers of neurodegeneration in Lewy body dementia, Alzheimer’s disease, frontotemporal dementia and progressive supranuclear palsy

Chouliaras, L., Thomas, A., Malpetti, M., Donaghy, P., Kane, J., Mak, E., Savulich, G., Prats-Sedano, M. A., Heslegrave, A. J., Zetterberg, H., et al. (2022) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp-2021-327788 · Cited by 199 · see citing works

Validation of Serum Neurofilament Light Chain as a Biomarker of Parkinson's Disease Progression

Mollenhauer, B., Dakna, M., Kruse, N., Galasko, D. R., Foroud, T., Zetterberg, H., Schade, S., Gera, R. G., Wang, W., Gao, F., et al. (2020) · Movement Disorders · doi:10.1002/mds.28206 · Cited by 198 · see citing works

Establishment of reference values for plasma neurofilament light based on healthy individuals aged 5–90 years

Simrén, J., Andréasson, U., Gobom, J., Suárez‐Calvet, M., Borroni, B., Gillberg, C., Nyberg, L. H., Ghidoni, R., Fernell, E., Johnson, M., et al. (2022) · Brain Communications · doi:10.1093/braincomms/fcac174 · Cited by 196 · see citing works

Consideration of sex and gender in Alzheimer's disease and related disorders from a global perspective

Mielke, M. M., Aggarwal, N. T., Vila‐Castelar, C., Agarwal, P., Arenaza‐Urquijo, E. M., Brett, B., Brugulat‐Serrat, A., DuBose, L. E., Eikelboom, W. S., Flatt, J., et al. (2022) · Alzheimer's & Dementia · doi:10.1002/alz.12662 · Cited by 198 · see citing works

Understanding multifactorial brain changes in type 2 diabetes: a biomarker perspective

Biessels, G. J., Nobili, F. M., Teunissen, C. E., Simó, R., & Scheltens, P. (2020) · The Lancet Neurology · doi:10.1016/s1474-4422(20)30139-3 · Cited by 195 · see citing works

Mitochondrial Dysfunction, Protein Misfolding and Neuroinflammation in Parkinson’s Disease: Roads to Biomarker Discovery

Picca, A., Guerra, F., Calvani, R., Romano, R., Coelho-Júnior, H. J., Bucci, C., & Marzetti, E. (2021) · Biomolecules · doi:10.3390/biom11101508 · Cited by 189 · see citing works

Detecting amyloid positivity in early Alzheimer's disease using combinations of plasma Aβ42/Aβ40 and p‐tau

Janelidze, S., Palmqvist, S., Leuzy, A., Stomrud, E., Verberk, I. M. W., Zetterberg, H., Ashton, N. J., Pesini, P., Sarasa, L., Allué, J. A., et al. (2022) · Alzheimer's & Dementia · doi:10.1002/alz.12395 · Cited by 188 · see citing works

SARS-CoV-2 Spike protein induces TLR4-mediated long-term cognitive dysfunction recapitulating post-COVID-19 syndrome in mice

Fontes-Dantas, F. L., Fernandes, G. G., Gutman, E. G., de Lima, E. V., Antonio, L. S., Hämmerle, M. B., Mota-Araujo, H. P., Colodeti, L. C., Araújo, S. M. B., Froz, G. M., et al. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.112189 · Cited by 176 · see citing works

Late-onset vs nonmendelian early-onset Alzheimer disease

Reitz, C., Rogaeva, E. A., & Beecham, G. W. (2020) · Neurology Genetics · doi:10.1212/nxg.0000000000000512 · Cited by 171 · see citing works

Neurofilament Light Chain as a Biomarker for Cognitive Decline in Parkinson Disease

Aamodt, W. W., Waligórska, T., Shen, J., Tropea, T. F., Siderowf, A. D., Weintraub, D. A., Grossman, M., Irwin, D. J., Wolk, D. A., Xie, S. X., et al. (2021) · Movement Disorders · doi:10.1002/mds.28779 · Cited by 172 · see citing works

Cerebrospinal fluid proteomics define the natural history of autosomal dominant Alzheimer’s disease

Johnson, E. C. B., Bian, S., Haque, R. U., Carter, E. K., Watson, C. M., Gordon, B. A., Ping, L., Duong, D. M., Epstein, M. P., McDade, E., et al. (2023) · Nature Medicine · doi:10.1038/s41591-023-02476-4 · Cited by 170 · see citing works

Cerebrospinal Fluid Biomarkers of Alzheimer’s Disease: Current Evidence and Future Perspectives

McGrowder, D. A., Miller, F. G., Vaz, K., Nwokocha, C. R., Wilson-Clarke, C. F., Anderson, M., Brown, J., Anderson-Jackson, L., Williams, L., Latore, L., et al. (2021) · Brain Sciences · doi:10.3390/brainsci11020215 · Cited by 167 · see citing works

Serum neurofilament light chain predicts long term clinical outcomes in multiple sclerosis

Thebault, S., Abdoli, M., Fereshtehnejad, S., Tessier, D. R., Tabard‐Cossa, V., & Freedman, M. S. (2020) · Scientific Reports · doi:10.1038/s41598-020-67504-6 · Cited by 163 · see citing works

Shared proteomic effects of cerebral atherosclerosis and Alzheimer’s disease on the human brain

Wingo, A. P., Fan, W., Duong, D. M., Gerasimov, E. S., Dammer, E. B., Liu, Y., Harerimana, N. V., White, B., Thambisetty, M., Troncoso, J. C., et al. (2020) · Nature Neuroscience · doi:10.1038/s41593-020-0635-5 · Cited by 161 · see citing works

An Update on Blood-Based Markers of Alzheimer’s Disease Using the SiMoA Platform

Li, D., & Mielke, M. M. (2019) · Neurology and Therapy · doi:10.1007/s40120-019-00164-5 · Cited by 147 · see citing works

Plasma neurofilament light chain in the presenilin 1 E280A autosomal dominant Alzheimer's disease kindred: a cross-sectional and longitudinal cohort study

Quiroz, Y. T., Zetterberg, H., Reiman, E. M., Chen, Y., Su, Y., Fox-Fuller, J. T., Garcia, G., Villegas, A., Sepulveda-Falla, D., Villada, M., et al. (2020) · The Lancet Neurology · doi:10.1016/s1474-4422(20)30137-x · Cited by 159 · see citing works

Serum neurofilament light as a biomarker in progressive multiple sclerosis

Kapoor, R., Smith, K. E., Allegretta, M., Arnold, D. L., Carroll, W. M., Comabella, M., Furlan, R., Harp, C. T., Kühle, J., Leppert, D., et al. (2020) · Neurology · doi:10.1212/wnl.0000000000010346 · Cited by 158 · see citing works

Sex Differences in Alzheimer’s Disease

Aggarwal, N. T., & Mielke, M. M. (2023) · Neurologic Clinics · doi:10.1016/j.ncl.2023.01.001 · Cited by 170 · see citing works

Diagnostic and prognostic value of serum NfL and p-Tau 181 in frontotemporal lobar degeneration

Benussi, A., Karikari, T. K., Ashton, N. J., Gazzina, S., Premi, E., Benussi, L., Ghidoni, R., Lantero‐Rodriguez, J., Emeršič, A., Simrén, J., et al. (2020) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2020-323487 · Cited by 156 · see citing works

Neurofilament Light Chain as Biomarker for Amyotrophic Lateral Sclerosis and Frontotemporal Dementia

Verde, F., Otto, M., & Silani, V. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.679199 · Cited by 152 · see citing works

Plasma Tau and Neurofilament Light in Frontotemporal Lobar Degeneration and Alzheimer Disease

Illán-Gala, I., Lleo, A., Karydas, A., Staffaroni, A. M., Zetterberg, H., Sivasankaran, R., Grinberg, L. T., Spina, S., Kramer, J. H., Ramos, E. M., et al. (2021) · Neurology · doi:10.1212/wnl.0000000000011226 · Cited by 150 · see citing works

Temporal order of clinical and biomarker changes in familial frontotemporal dementia

Staffaroni, A. M., Quintana, M., Wendelberger, B., Heuer, H. W., Russell, L. L., Cobigo, Y., Wolf, A., Goh, S.-Y. M., Petrucelli, L., Gendron, T. F., et al. (2022) · Nature Medicine · doi:10.1038/s41591-022-01942-9 · Cited by 140 · see citing works

Neurodegenerative Disorders of Alzheimer, Parkinsonism, Amyotrophic Lateral Sclerosis and Multiple Sclerosis: An Early Diagnostic Approach for Precision Treatment

Pathak, N., Vimal, S. K., Tandon, I., Agrawal, L., Cao, H., & Bhattacharyya, S. (2021) · Metabolic Brain Disease · doi:10.1007/s11011-021-00800-w · Cited by 149 · see citing works

Evolving concepts in progressive supranuclear palsy and other 4-repeat tauopathies

Stamelou, M., Respondek, G., Giagkou, N., Whitwell, J. L., Kovács, G. G., & Höglinger, G. U. (2021) · Nature Reviews Neurology · doi:10.1038/s41582-021-00541-5 · Cited by 143 · see citing works

NfL as a biomarker for neurodegeneration and survival in Parkinson disease

Bäckström, D. C., Linder, J., Mo, S. J., Riklund, K., Zetterberg, H., Blennow, K., Forsgren, L., & Lenfeldt, N. (2020) · Neurology · doi:10.1212/wnl.0000000000010084 · Cited by 138 · see citing works

Age‐ and disease‐specific reference values for neurofilament light presented in an online interactive support interface

Vermunt, L., Otte, M., Verberk, I. M. W., Killestein, J., Lemstra, A. W., van der Flier, W. M., Pijnenburg, Y. A. L., Vijverberg, E. G. B., Bouwman, F. H., Gravesteijn, G., et al. (2022) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.51676 · Cited by 138 · see citing works

Astrocyte biomarkers GFAP and YKL‐40 mediate early Alzheimer's disease progression

Pelkmans, W., Shekari, M., Brugulat‐Serrat, A., Sánchez‐Benavides, G., Minguillón, C., Fauria, K., Molinuevo, J. L., Grau‐Rivera, O., González Escalante, A., Kollmorgen, G., et al. (2024) · Alzheimer's & Dementia · doi:10.1002/alz.13450 · Cited by 122 · see citing works

Fluid biomarkers in frontotemporal dementia: past, present and future

Swift, I. J., Sogorb-Esteve, A., Heller, C., Synofzik, M., Otto, M., Graff, C., Galimberti, D., Todd, E., Heslegrave, A. J., van der Ende, E. L., et al. (2021) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp-2020-323520 · Cited by 122 · see citing works

Effects of IgLON5 Antibodies on Neuronal Cytoskeleton: A Link between Autoimmunity and Neurodegeneration

Landa, J., Gaig, C., Plagumà, J., Saiz, A., Antonell, A., Sánchez‐Valle, R., Dalmau, J. O., Graus, F., & Sabater, L. (2020) · Annals of Neurology · doi:10.1002/ana.25857 · Cited by 121 · see citing works

Stage-specific links between plasma neurofilament light and imaging biomarkers of Alzheimer’s disease

Benedet, A. L., Leuzy, A., Pascoal, T. A., Ashton, N. J., Mathotaarachchi, S. S., Savard, M., Therriault, J., Kang, M. S., Chamoun, M., Schöll, M., et al. (2020) · Brain · doi:10.1093/brain/awaa342 · Cited by 122 · see citing works

The Evolution of Neurofilament Light Chain in Multiple Sclerosis

Ferreira-Atuesta, C., Reyes, S., Giovanonni, G., & Gnanapavan, S. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.642384 · Cited by 115 · see citing works

The multifaceted role of neurofilament light chain protein in non-primary neurological diseases

Abu‐Rumeileh, S., Abdelhak, A., Foschi, M., D’Anna, L., Russo, M., Steinacker, P., Kühle, J., Tumani, H., Blennow, K., & Otto, M. (2022) · Brain · doi:10.1093/brain/awac328 · Cited by 119 · see citing works

Gut microbiota–driven brain Aβ amyloidosis in mice requires microglia

Dodiya, H. B., Lutz, H. L., Weigle, I. Q., Patel, P., Michalkiewicz, J., Roman-Santiago, C. J., Zhang, C. M., Liang, Y., Srinath, A., Zhang, X., et al. (2022) · Journal of Experimental Medicine · doi:10.1084/jem.20200895 · Cited by 120 · see citing works

A randomized placebo‐controlled phase 3 study of mesenchymal stem cells induced to secrete high levels of neurotrophic factors in amyotrophic lateral sclerosis

Cudkowicz, M., Lindborg, S. R., Goyal, N., Miller, R. G., Burford, M. J., Berry, J. D., Nicholson, K. A., Mozaffar, T., Katz, J., Jenkins, L., et al. (2021) · Muscle & Nerve · doi:10.1002/mus.27472 · Cited by 117 · see citing works

The potential of blood neurofilament light as a marker of neurodegeneration for Alzheimer's disease

Jung, Y., & Damoiseaux, J. S. (2023) · Brain · doi:10.1093/brain/awad267 · Cited by 117 · see citing works

“Bridging the Gap” Everything that Could Have Been Avoided If We Had Applied Gender Medicine, Pharmacogenetics and Personalized Medicine in the Gender-Omics and Sex-Omics Era

Gemmati, D., Varani, K., Bramanti, B., Piva, R., Bonaccorsi, G., Trentini, A., Manfrinato, M. C., Tisato, V., Carè, A., & Bellini, T. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms21010296 · Cited by 115 · see citing works

Mutant huntingtin and neurofilament light have distinct longitudinal dynamics in Huntington’s disease

Rodrigues, F. B., Byrne, L. M., Tortelli, R., Johnson, E. B., Wijeratne, P. A., Arridge, M., Vita, E. D., Ghazaleh, N., Houghton, R., Furby, H., et al. (2020) · Science Translational Medicine · doi:10.1126/scitranslmed.abc2888 · Cited by 114 · see citing works

Differential levels of Neurofilament Light protein in cerebrospinal fluid in patients with a wide range of neurodegenerative disorders

Delaby, C., Alcolea, D. A., Carmona‐Iragui, M., Illán‐Gala, I., Morenas‐Rodríguez, E., Barroeta, I., Altuna, M., Estellés, T., Santos‐Santos, M., Turón‐Sans, J., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-66090-x · Cited by 110 · see citing works

Neurofilaments in motor neuron disorders: towards promising diagnostic and prognostic biomarkers

Zucchi, E., Bonetto, V., Sorarú, G., Martinelli, I., Parchi, P., Liguori, R., & Mandrioli, J. (2020) · Molecular Neurodegeneration · doi:10.1186/s13024-020-00406-3 · Cited by 107 · see citing works

Perspectives and challenges in patient stratification in Alzheimer’s disease

Abdelnour, C., Agosta, F., Bozzali, M., Fougère, B., Iwata, A., Nilforooshan, R., Takada, L. T., Viñuela, F., & Traber, M. (2022) · Alzheimer's Research & Therapy · doi:10.1186/s13195-022-01055-y · Cited by 108 · see citing works

Alzheimer's disease biomarkers in Black and non-Hispanic White cohorts: a contextualized review of the evidence

Gleason, C. E., Zuelsdorff, M., Gooding, D. C., Kind, A. J. H., Johnson, A. L., James, T. T., Lambrou, N. H., Wyman, M. F., Ketchum, F. B., Gee, A., et al. (2022) · Alzheimer's & Dementia · doi:10.1002/alz.12511 · Cited by 104 · see citing works

Blood Neurofilament Light Chain: The Neurologist’s Troponin?

Thebault, S., Booth, R. A., & Freedman, M. S. (2020) · Biomedicines · doi:10.3390/biomedicines8110523 · Cited by 101 · see citing works

Contributors to Serum <scp>NfL</scp> Levels in People without Neurologic Disease

Fitzgerald, K. C., Sotirchos, E. S., Smith, M. D., Lord, H., DuVal, A., Mowry, E. M., & Calabresi, P. A. (2022) · Annals of Neurology · doi:10.1002/ana.26446 · Cited by 101 · see citing works

Neurofilament-Light, a Promising Biomarker: Analytical, Metrological and Clinical Challenges

Coppens, S., Lehmann, S., Hopley, C. J., & Hirtz, C. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241411624 · Cited by 99 · see citing works

Alpha-synuclein: a pathological factor with Aβ and tau and biomarker in Alzheimer’s disease

Shim, K. H., Kang, M. J., Youn, Y. C., An, S. S. A., & Kim, S. (2022) · Alzheimer s Research & Therapy · doi:10.1186/s13195-022-01150-0 · Cited by 98 · see citing works

CSF or Serum Neurofilament Light Added to α‐Synuclein Panel Discriminates Parkinson's From Controls

Oosterveld, L. P., Verberk, I. M. W., Majbour, N. K., El‐Agnaf, O. M. A., Weinstein, H. C., Berendse, H. W., Teunissen, C. E., & van de Berg, W. D. J. (2019) · Movement Disorders · doi:10.1002/mds.27897 · Cited by 93 · see citing works

Differential diagnostic performance of a panel of plasma biomarkers for different types of dementia

Thijssen, E. H., Verberk, I. M. W., Kindermans, J., Abramian, A., Vanbrabant, J., Ball, A. J., Pijnenburg, Y. A. L., Lemstra, A. W., van der Flier, W. M., Stoops, E., et al. (2022) · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · doi:10.1002/dad2.12285 · Cited by 86 · see citing works

Timing of Biomarker Changes in Sporadic Alzheimer's Disease in Estimated Years from Symptom Onset

Li, Y., Yen, D., Hendrix, R. D., Gordon, B. A., Dlamini, S. L., Barthélemy, N. R., Aschenbrenner, A. J., Henson, R. L., Herries, E. M., Volluz, K., et al. (2024) · Annals of Neurology · doi:10.1002/ana.26891 · Cited by 86 · see citing works

Neurofilament light chain is a promising serum biomarker in spinocerebellar ataxia type 3

Li, Q., Dong, Y., Yang, L., Xie, J., Ma, Y., Du, Y., Cheng, H., Wang, N., & Wu, Z. (2019) · Molecular Neurodegeneration · doi:10.1186/s13024-019-0338-0 · Cited by 87 · see citing works

Artificial intelligence-driven multi-omics approaches in Alzheimer's disease: Progress, challenges, and future directions

Ren, F., Wei, J., Chen, Q., Hu, M., Yu, L., Mi, J., Zhou, X., Qin, D., Wu, J., & Wu, A. (2025) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2025.07.030 · Cited by 97 · see citing works

Plasma glial fibrillary acidic protein and neurofilament light chain for the diagnostic and prognostic evaluation of frontotemporal dementia

Zhu, N., Santos-Santos, M., Illán-Gala, I., Montal, V., Estellés, T., Barroeta, I., Altuna, M., Arranz, J., Muñoz, L., Belbin, O., et al. (2021) · Translational Neurodegeneration · doi:10.1186/s40035-021-00275-w · Cited by 86 · see citing works

Neurofilaments in disease: what do we know?

Gordon, B. A. (2020) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2020.02.001 · Cited by 83 · see citing works

Pathophysiology of neurodegenerative diseases: An interplay among axonal transport failure, oxidative stress, and inflammation?

Tesco, G., & Lomoio, S. (2022) · Seminars in Immunology · doi:10.1016/j.smim.2022.101628 · Cited by 91 · see citing works

Increased serum neurofilament light chain concentration indicates poor outcome in Guillain-Barré syndrome

Altmann, P., Simoni, D. D., Kaider, A., Ludwig, B., Rath, J., Leutmezer, F., Zimprich, F., Höftberger, R., Lunn, M. P., Heslegrave, A., et al. (2020) · Journal of Neuroinflammation · doi:10.1186/s12974-020-01737-0 · Cited by 81 · see citing works

Update on CSF Biomarkers in Parkinson’s Disease

Kwon, E. H., Tennagels, S., Gold, R., Gerwert, K. B., Beyer, L., & Tönges, L. (2022) · Biomolecules · doi:10.3390/biom12020329 · Cited by 79 · see citing works

Neuronal and glial CSF biomarkers in multiple sclerosis: a systematic review and meta-analysis

Momtazmanesh, S., Shobeiri, P., Saghazadeh, A., Teunissen, C. E., Burman, J., Szalárdy, L., Klivènyi, P., Bartoš, A., Fernandes, A. M. A., & Rezaei, N. (2021) · Reviews in the Neurosciences · doi:10.1515/revneuro-2020-0145 · Cited by 78 · see citing works

Inflammatory leptomeningeal cytokines mediate COVID-19 neurologic symptoms in cancer patients

Remsik, J., Wilcox, J. A., Babady, N. E., McMillen, T. A., Vachha, B. A., Halpern, N. A., Dhawan, V., Rosenblum, M., Iacobuzio-Donahue, C. A., Avila, E. K., et al. (2021) · Cancer Cell · doi:10.1016/j.ccell.2021.01.007 · Cited by 77 · see citing works

Altered neuroaxonal integrity in schizophrenia and major depressive disorder assessed with neurofilament light chain in serum

Bavato, F., Cathomas, F., Klaus, F., Guetter, K., Barro, C., Maceski, A. M., Seifritz, E., Kühle, J., Kaiser, S., & Quednow, B. B. (2021) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2021.05.072 · Cited by 77 · see citing works

Multi-analyte proteomic analysis identifies blood-based neuroinflammation, cerebrovascular and synaptic biomarkers in preclinical Alzheimer’s disease

Zeng, X., Lafferty, T. K., Sehrawat, A., Chen, Y., Ferreira, P. C. L., Bellaver, B., Povala, G., Kamboh, M. I., Klunk, W. E., Cohen, A. D., et al. (2024) · Molecular Neurodegeneration · doi:10.1186/s13024-024-00753-5 · Cited by 87 · see citing works

Associations of longitudinal plasma p-tau181 and NfL with tau-PET, Aβ-PET and cognition

Rauchmann, B. S., Schneider-Axmann, T., & Perneczky, R. (2021) · Journal of Neurology, Neurosurgery &amp; Psychiatry · doi:10.1136/jnnp-2020-325537 · Cited by 74 · see citing works

Increasing the reproducibility of fluid biomarker studies in neurodegenerative studies

Mattsson, N., Palmqvist, S., Blennow, K., & Hansson, O. (2020) · Nature Communications · doi:10.1038/s41467-020-19957-6 · Cited by 69 · see citing works

Diagnostic Performance and Clinical Applicability of Blood-Based Biomarkers in a Prospective Memory Clinic Cohort

Sarto, J., Ruiz-García, R., Guillén, N., Ramos-Campoy, Ó., Falgàs, N., Esteller, D., Contador, J., Fernández, G., González, Y., Tort-Merino, A., et al. (2023) · Neurology · doi:10.1212/wnl.0000000000201597 · Cited by 71 · see citing works

Comparison of CSF biomarkers in Down syndrome and autosomal dominant Alzheimer's disease: a cross-sectional study

Fagan, A. M., Henson, R. L., Li, Y., Boerwinkle, A. H., Xiong, C., Bateman, R. J., Goate, A., Ances, B. M., Doran, E. W., Christian, B. T., et al. (2021) · The Lancet Neurology · doi:10.1016/s1474-4422(21)00139-3 · Cited by 70 · see citing works

Plasma neurodegeneration biomarker concentrations associate with glymphatic and meningeal lymphatic measures in neurological disorders

Eide, P. K., Lashkarivand, A., Pripp, A. H., Valnes, L. M., Hovd, M. H., Ringstad, G. A., Blennow, K., & Zetterberg, H. (2023) · Nature Communications · doi:10.1038/s41467-023-37685-5 · Cited by 69 · see citing works

The Role of P2X7 Receptor in Alzheimer’s Disease

Francistiová, L., Bianchi, C., Lauro, C. D., Sebastián‐Serrano, Á., de Diego-García, L., Kobolák, J., Dinnyés, A., & Dı́az-Hernández, M. (2020) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2020.00094 · Cited by 69 · see citing works

Potential biological contributers to the sex difference in multiple sclerosis progression

Álvarez‐Sánchez, N., & Dunn, S. E. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1175874 · Cited by 71 · see citing works

Biomarkers in amyotrophic lateral sclerosis: current status and future prospects

McMackin, R., Bede, P., Ingre, C., Malaspina, A., & Hardiman, O. M. (2023) · Nature Reviews Neurology · doi:10.1038/s41582-023-00891-2 · Cited by 69 · see citing works

Association of biological sex with clinical outcomes and biomarkers of Alzheimer’s disease in adults with Down syndrome

Iulita, M. F., Bejanin, A., Vilaplana, E., Carmona-Iragui, M., Benejam, B., Videla, L., Barroeta, I., Fernández, S., Altuna, M., Pegueroles, J., et al. (2023) · Brain Communications · doi:10.1093/braincomms/fcad074 · Cited by 68 · see citing works

Neurofilaments: The C-Reactive Protein of Neurology

Lambertsen, K. L., Soares, C. B., Gaist, D., & Nielsen, H. H. (2020) · Brain Sciences · doi:10.3390/brainsci10010056 · Cited by 66 · see citing works

A longitudinal examination of plasma neurofilament light and total tau for the clinical detection and monitoring of Alzheimer's disease

Sugarman, M. A., Zetterberg, H., Blennow, K., Tripodis, Y., McKee, A. C., Stein, T. D., Martin, B. M., Palmisano, J. N., Steinberg, E. G., Simkin, I., et al. (2020) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2020.05.011 · Cited by 68 · see citing works

Significance of Blood and Cerebrospinal Fluid Biomarkers for Alzheimer’s Disease: Sensitivity, Specificity and Potential for Clinical Use

d’Abramo, C., D'adamio, L., & Giliberto, L. (2020) · Journal of Personalized Medicine · doi:10.3390/jpm10030116 · Cited by 68 · see citing works

Plasma neurofilament light chain predicts cerebellar atrophy and clinical progression in spinocerebellar ataxia

Coarelli, G., Darios, F. D., Petit, E., Dorgham, K., Adanyeguh, I. M., Petit, E., Brice, A., Mochel, F., & Dürr, A. (2021) · Neurobiology of Disease · doi:10.1016/j.nbd.2021.105311 · Cited by 67 · see citing works

Proteomic analysis reveals a biosignature of decreased synaptic protein in cerebrospinal fluid of major depressive disorder

Shweiki, M. R. A., Oeckl, P., Steinacker, P., Barschke, P., Dorner‐Ciossek, C., Hengerer, B., Schönfeldt‐Lecuona, C., & Otto, M. (2020) · Translational Psychiatry · doi:10.1038/s41398-020-0825-7 · Cited by 66 · see citing works

The path to biomarker-based diagnostic criteria for the spectrum of neurodegenerative diseases

Baldacci, F., Mazzucchi, S., Vecchia, A. D., Giampietri, L., Giannini, N., Koronyo‐Hamaoui, M., Ceravolo, R., Siciliano, G., Bonuccelli, U., Elahi, F. M., et al. (2020) · Expert Review of Molecular Diagnostics · doi:10.1080/14737159.2020.1731306 · Cited by 64 · see citing works

Serum neurofilament light chain withstands delayed freezing and repeated thawing

Altmann, P., Leutmezer, F., Zach, H., Wurm, R., Stattmann, M., Ponleitner, M., Petzold, A., Zetterberg, H., Berger, T., Rommer, P., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-77098-8 · Cited by 67 · see citing works

Consideration of Sex Differences in the Measurement and Interpretation of Alzheimer Disease-Related Biofluid-Based Biomarkers

Mielke, M. M. (2019) · The Journal of Applied Laboratory Medicine · doi:10.1373/jalm.2019.030023 · Cited by 65 · see citing works

An Update on the Critical Role of α-Synuclein in Parkinson’s Disease and Other Synucleinopathies: from Tissue to Cellular and Molecular Levels

Serratos, I. N., Hernández‐Pérez, E., Campos, C., Aschner, M., & Santamarı́a, A. (2021) · Molecular Neurobiology · doi:10.1007/s12035-021-02596-3 · Cited by 64 · see citing works

P1‐247: CEREBROSPINAL FLUID NEUROFILAMENT LIGHT PROTEIN AS A DIFFERENTIAL DIAGNOSIS BIOMARKER IN NEUROLOGICAL DISEASES: A SYSTEMATIC REVIEW AND METAANALYSIS

Bridel, C., van Wieringen, W. N., Zettenberg, H., Visser, P. J., Tijms, B. M., & Teunissen, C. E. (2018) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2018.06.252 · Cited by 2 · see citing works

P4‐218: SEX DIFFERENCES IN CEREBROSPINAL FLUID NEUROFILAMENT LIGHT CHAIN LEVELS ARE CONSISTENT ACROSS COHORTS

Alcolea, D. A., Vilaplana, E., Muñoz, L., Illán‐Gala, I., Morenas‐Rodríguez, E., Estellés, T., Barroeta, I., Carmona‐Iragui, M., Delaby, C., Lehmann, S., et al. (2019) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2019.06.3881

Neurofilament light chain reference values in serum and cerebrospinal fluid: a bi-compartmental analysis in neurological diseasesPreprint

Halbgebauer, S., Klose, V., Fazeli, B., Klassen, P., Alexudis, C., Nagel, G., Rosenbohm, A., Rothenbacher, D., José, N. G. D. S., Witzel, S., et al. (2024) · medRxiv · doi:10.1101/2024.11.21.24317697 · Cited by 3 · see citing works

Differential levels of Neurofilament Light protein in cerebrospinal fluid in patients with a wide range of neurodegenerative disorders

Delaby, C., Alcolea, D. A., Carmona‐Iragui, M., Illán‐Gala, I., Morenas‐Rodríguez, E., Barroeta, I., Altuna, M., Estellés, T., Santos‐Santos, M., Turón‐Sans, J., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-66090-x · Cited by 110 · see citing works

A new enzyme-linked immunosorbent assay for neurofilament light in cerebrospinal fluid: analytical validation and clinical evaluation

Gaetani, L., Höglund, K., Parnetti, L., Pujol-Calderón, F., Becker, B., Eusebi, P., Sarchielli, P., Calabresi, P., Filippo, M. D., Zetterberg, H., et al. (2018) · Alzheimer s Research & Therapy · doi:10.1186/s13195-018-0339-1 · Cited by 174 · see citing works